Skip to content

Self-Care for Dementia Caregivers

Self-Care for Dementia Caregivers Using the myRhythmWatch

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05309577
Acronym
Care2
Enrollment
21
Registered
2022-04-04
Start date
2023-03-07
Completion date
2025-03-10
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Alzheimer Disease, Circadian Rhythm Disorders, Dementia, Eating, Healthy, Mental Disorder, Physical Inactivity, Prodromal Symptoms, Sleep

Keywords

Caregivers, Carers, Alzheimer Disease, Alzheimer Dementia, Dementia, Twenty-Four Hour Rhythm, Geriatrics, Self Care, Circadian Rhythm

Brief summary

The Self-care for Dementia Caregivers Study is a behavioral health intervention that uses digital monitoring tools and motivational health coaching to help caregivers of persons with dementia engage in a regular routine of sleep and activity. Participants wear an apple watch for the objective collection of sleep-wake rhythms. They receive personalized feedback on their sleep-wake rhythms via a new app. Health coaches call participants weekly, for up to 6 weeks to help participants meet their health/sleep goals and promote self-knowledge of regular routines. Participants will help the study team improve the design elements and content of the mobile app. The goal of this intervention is to reduce depressive and insomnia symptoms.

Detailed description

Caregivers of family members with Alzheimer's Disease (AD) and AD-related dementias (ADRD) experience high rates of psychological stress, physical impairments, and often, disruptions in normal daily activities. Caregivers must be alert both at night and during the day, and often on an inconsistent schedule. As a result, caregivers are less likely to sleep, exercise, and be socially active on a regular schedule. Disruptions of these biological and behavioral time cues, or "zeitgebers", in turn decrease the stability of the body's biological clock, placing caregivers at high risk for adverse health outcomes related to an out-of-sync biological clock (e.g. diabetes, cardiovascular disease, and depression, among others). Caregivers of individuals with ADRD experience worse health outcomes compared with other types of caregivers, likely due to more heavily or frequently disrupted schedules. For this research study, up to 25 individuals aged 50 and older who are providing care for a family member with mild-to-moderate dementia will be included. Data from 5 participants will be used for the development of an intervention manual (NIH Stage Model IA). A small pilot study will be conducted (NIH Stage Model IB) in which 20 participants will use a new mobile app - my rhythm watch - for up to 6 weeks. Objective actigraphic measures of the 24-hour pattern of sleep and daytime activity - known as the circadian rest-activity rhythm (RAR) - will be measured continuously via the apple watch to evaluate circadian rhythms as a potential intervention target/mechanism of action. The investigators will measure the regularity, timing, and amplitude of behavioral patterns over a 24-hour period. Participants will be assessed at baseline, post-intervention, and 3-months post-intervention. Initially our plan was to focus an intervention on promoting self-care and reducing caregiving burden. However, in designing the trial, we switched the focus to the circadian-informed, behavioral activation-based approach that aimed to improve sleep and mood in caregivers. Therefore, the two main outcomes of interest were measures of depression symptom severity and insomnia symptom severity. The study as described in the original registration (April 2022) never proceeded. The registration has been revised to reflect the study as modified after securing a technology partner (per funding requirements) and prior to study initiation

Interventions

Participants (n=20) will wear a iWatch to continuously measure their objective sleep-wake activity. The iWatch data sync to the new myRhythmWatch app, where participants will monitor their behavioral rhythm. Participants will also interact with a 'health coach' about their recorded behaviors weekly. This health coach will use motivational interviewing to enhance older adult caregivers' confidence and intrinsic motivation to engage in regular self-care.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Activity Rhythm Solutions Corporation
CollaboratorUNKNOWN
Oregon Health and Science University
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

for ADRD patients include: * being ≥60 years * having been diagnosed with Alzheimer's disease, vascular dementia, mixed Alzheimer's/vascular dementia, or frontotemporal dementia * living with their caregiver * being willing to wear the watch and participate in assessments and calls Inclusion criteria for ADRD caregivers include: * being a primary caregiver for an ADRD patient * being ≥50 years * experiencing stress/strain related to caregiving * the person being cared for has problems with sleep or keeping a consistent routine * scoring ≥5 on the PHQ-9 (experiencing depression symptoms) * living with their care recipient * being willing to try the app and participate in assessments and calls

Exclusion criteria

for ADRD patients include: * being less than 60 years * not having a diagnosis of ADRD * not living with their caregiver * not being willing to wear the watch and participate in assessments and calls

Design outcomes

Primary

MeasureTime frameDescription
Pre/Post Change in Depressive SymptomsUp to 6 weeksThe 9-item Patient Health Questionnaire (PHQ-9) scale is a self-reported questionnaire to be completed by the participant that assesses severity of depression. The PHQ-9 will be administered throughout the study to assess changes in depressive symptoms pre- and post-intervention. A minimum score on this metric is a 0, indicating no impact to patient health, and ranges up to a maximum score of 27, indicating more severe impacts to patient health.
Pre/Post Change in Insomnia SymptomsUp to 6 weeksThe 7-item Insomnia Severity Index (ISI) is a self-reported questionnaire to be completed by the participant that assesses severity of insomnia. The ISI will be administered throughout the study to assess changes in insomnia symptoms pre- and post-intervention. A minimum score on this metric is a 0, indicating no impact to patient health, and ranges up to a maximum score of 28, indicating more severe impacts to patient health.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSarah T Stahl, PhD

University of Pittsburgh, Assistant Professor of Psychiatry and Clinical and Translational Science

Participant flow

Recruitment details

This study recruited dementia caregivers (CG) from university-affiliated research registries. Eligible/interested dementia caregivers were screened for whether their care recipients, a person with dementia (PWD), would be eligible/interested in using the myRW app to track and monitor daily rhythms. Of the 25 dementia CGs we screened, 15 CGs were enrolled and allocated to the intervention; and 6 PWD were included in the intervention rendering a total sample of 21.

Pre-assignment details

This single-arm pilot trial enrolled participants between March 2023 and April 2024 in Pittsburgh, PA.

Baseline characteristics

Characteristic
Age, Continuous81.45 years
STANDARD_DEVIATION 8.46
Depression symptoms6.64 score on a scale
STANDARD_DEVIATION 5
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Insomnia symptoms8.60 score on a scale
STANDARD_DEVIATION 5.41
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
14 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 6
other
Total, other adverse events
0 / 150 / 6
serious
Total, serious adverse events
0 / 150 / 6

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026